查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198700

泌尿动力学设备市场——增长、趋势和预测 (2023-2028)

Urodynamic Equipment Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，泌尿动力学设备市场预计将以 6.3% 的复合年增长率增长。

COVID-19 对泌尿动力学设备市场产生了重大影响。 政府的封锁和限制减少了泌尿科服务，包括门诊预约、门诊检查和治疗以及泌尿外科手术。 例如，从 2022 年 8 月发表在 European Urology 上的一篇文章中，沙特观察到 28% 的门诊就诊、30% 的门诊调查和 31% 的泌尿外科手术被推迟了八週或更长时间。 此外，根据同一消息来源，与恶性疾病相比，良性疾病的泌尿科服务受到的影响更大。 因此，在 COVID-19 大流行期间，泌尿外科诊断和手术的延误影响了对尿流动力学设备的需求。 然而，政府放鬆管制、恢復泌尿外科服务和外科手术以及增加医院就诊次数预计将增加对尿动力学设备的需求，推动预测期内的市场增长。

泌尿系统疾病和残疾负担加重、老年人口增加以及泌尿动力学设备技术进步等因素正在推动市场增长。 膀胱癌、膀胱感染和炎症、肾结石和尿失禁等泌尿系统疾病的患病率上升是市场增长的主要驱动力。 例如，根据 2022 年 6 月发表的一篇文章，尿路感染是全球 16 至 35 岁女性最常见的细菌感染。 根据同一消息来源，每年有 10% 的女性经历感染，40% 至 60% 或更多的女性一生中至少经历一次感染。 因此，对尿动力学治疗和症状和疾病诊断的需求不断增加，市场增长有望进一步加快。

此外，根据国家医学图书馆发表的一篇文章，到 2022 年 6 月，全球估计每年将有 4.23 亿人经历某种形式的尿失禁 (UI)。 此外，根据 2021 年 2 月发表的一篇文章，大约有二分之一的 50 岁以上女性经历过尿失禁问题，这被定义为无法控制的小便洩漏。积载被描述为从几滴到完全意外的任何事情. 因此，预计尿失禁的高患病率将增加对导尿管的需求，以帮助膀胱排空，从而推动市场增长。 此外，老年人尿失禁和其他泌尿系统疾病的患病率较高，对患者的生活质量产生负面影响。 与年龄相关的下尿路变化，如膀胱容量和饱腹感下降、勃起肌收缩力下降、盆底肌阻力下降和残余尿量增加，是导致尿失禁在人群中流行的因素之一。增加 此外，据说老年人患尿路结石的风险增加，是因为阴道内的雌激素减少，阴道环境发生变化，更容易发生细菌感染。

此外，公司加大力度开发技术先进的设备和产品也促进了市场增长。 例如，2022 年 3 月，德里的 Lok Nayak 医院启动了一个尿动力学视频实验室，提供泌尿道和膀胱的实时成像和即时生物反馈。 该实验室拥有先进的膀胱动力学检查设备，有助于管理患有泌尿系统异常和疾病的儿童。 因此，由于上述因素，预计所研究的市场将在预测期内增长。 然而，在预测期内，严格的医疗器械验证监管政策可能会阻碍尿流动力学器械市场的增长。

尿动力学设备市场趋势

预计在预测期内，尿流部分将占据重要的市场份额

由于尿失禁等泌尿系统疾病增多、人口老龄化导致慢性病患病率增加以及技术先进的产品等因素，预计尿流动力学设备市场在预测期内将出现显着增长。

Uroflowmetry 是一种非侵入性诊断测试，用于诊断下尿路症状。 它测量从体内释放的尿液量、释放速率和释放所需的时间。 它还有助于确定小便时的主要原因或困难。 因此，与其他仪器相比，这些类型的仪器测量尿量和评估导致排尿困难的确切原因和泌尿系统疾病类型的准确性很高。 出于这个原因，许多疑似下尿路功能障碍的患者更喜欢使用它而不是其他设备。

此外，男性良性前列腺增生症 (BPH) 发病率的上升也增加了对尿流□□率检测的需求，预计这将在预测期内增加该细分市场的增长。 例如，国家生物技术信息中心 2021 年 7 月发表的一篇论文发现，BPH 的患病率在 60 多岁的男性中高达 50% 至 60%，在 70 岁以上的男性中高达 80% 至 90%。事情得到证实。 此外，越来越多的企业在开发安全有效的诊断测试以测量人群泌尿系统状况方面的活动也有助于市场增长。 例如，2021 年 11 月，医疗设备製造商 Oruba 将推出 Oruflow，这是第一款自动操作的尿流率计，使筛查过程对患者和医生都卫生、安全、舒适且简化。它正在销售。 因此，由于上述因素，预计该行业在预测期内将显着增长。

预计在预测期内北美将占据主要市场份额

预计在预测期内，北美将占据泌尿动力学设备市场的很大份额。 推动市场增长的因素是该地区泌尿系统疾病发病率的增加和泌尿动力学设备技术的不断进步。 预计该地区不断增长的老年人口也将成为市场增长的一个因素。 例如，NCBI 于 2021 年 2 月发表的一篇文章证实，尿失禁对女性的影响超过男性，美国 60 岁以上的女性显着增加。 另外，根据弗雷泽研究所发布的统计数据，到2022年7月，加拿大约有19%的人口将超过65岁，预计到2030年这一数字将达到22.5%。 衰老会增加出现膀胱问题的风险，例如膀胱控制问题、漏尿和尿失禁。 因此，预计在预测期内，对用于诊断和治疗泌尿系统疾病的尿动力学设备的需求将会增加。

此外，该地区越来越多的产品批准和产品发布也促进了市场增长。 例如，2021 年 7 月，Gemini Medical Technologies 推出了 MEDKONSULT Medical Technology 的一系列新尿动力学设备。 同样在 2021 年 2 月，加拿大卫生部批准了 Bactiguard 的带有温度传感器的 TempSensor 导管，以降低重症患者发生导管相关性尿路感染（CAUTI）等继发感染的风险。 因此，由于上述因素，预计所研究的市场在预测期内将显着增长。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 增加泌尿系统疾病和病症的负担
    • 老年人口增加
    • 泌尿动力学装置技术进展
  • 市场製约因素
    • 严格的医疗器械验证监管政策
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按产品类型
    • 泌尿动力学装置
      • 膀胱压力计
      • 尿流率测量装置
      • 环境泌尿系统
      • 肌电图
      • 视频尿压计
    • 尿动力学耗材
      • 导尿管
      • 尿流泵和换能器套件
  • 最终用户
    • 医院
    • 门诊中心
    • 其他最终用户
  • 按地区细分
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Medtronic Plc
    • Coloplast□
    • Albyn Medical S.L.
    • Boston Scientific Corporation
    • Coopersurgical, Inc.
    • Laborie（Medical Measurement Systems B.V.）
    • Verathon, Inc.（Roper Technologies, Inc.）
    • Karl Storz SE & Co. KG
    • Olympus Corporation
    • Gemini Medical Technologies
    • White Bridge Investments S.p.A（Delta Med S.p.A.）

第7章 市场机会与今后动向

简介目录
Product Code: 67745

The urodynamic equipment market is expected to register a CAGR of 6.3% during the forecast period.

COVID-19 had a significant impact on the urodynamic equipment market. The lockdown measures and the restrictions imposed by the government reduced urological services, including outpatient clinic appointments, outpatient investigations and treatments, and urological surgery. For instance, from an article published in European Urology in August 2022, it has been observed that 28% of outpatient clinics, 30% of outpatient investigations, and 31% of urological surgeries were delayed for more than eight weeks in Saudi Arabia. In addition, as per the same source, urological services for benign conditions were more affected as compared to malignant conditions. Thus, delayed urological diagnostic and surgical procedures have impacted the demand for urodynamic equipment during the COVID-19 pandemic. However, relaxed government restrictions, resumed urological services and surgical procedures, as well as increased hospital visits, are expected to increase the demand for urodynamic equipment, which is anticipated to fuel market growth over the forecast period.

The factors such as the increasing burden of urologic diseases and disorders, the growing geriatric population, and technological advancements in urodynamic equipment are boosting the market growth. The increasing cases of urologic diseases such as bladder cancer, infection or inflammation of the urinary bladder, kidney stones, urinary incontinence problems, and others among the population is the key factor driving market growth. For instance, as per an article published in June 2022, urinary tract infections are the most common bacterial infections in women between the ages of 16 and 35 years globally. As per the same source, 10% of women experience an infection each year, and more than 40% to 60% experience an infection at least once in their lifetimes. This is expected to increase the need for urodynamic treatment and diagnosis of the condition or diseases, which is further anticipated to fuel market growth.

Additionally, as per an article published by the National Library of Medicine, in June 2022, an estimated 423 million people experience some form of urinary incontinence (UI) worldwide every year. Also, according to an article published in February 2021, nearly 1 in 2 women over the age of 50 experience problems with urinary incontinence, which is the uncontrolled leaking of pee and can range from a few drops of leakage to a full accident. Thus, the high prevalence of UI among the population is expected to raise the need for urinary catheters that helps in draining the bladder, hence propelling the market growth. Furthermore, the prevalence of urinary incontinence and other urological diseases is higher in elderly patients and has a negative impact on their quality of life. The changes associated with aging in the lower urinary system, such as decreased bladder capacity and feeling of fullness, decreased rate of detrusor muscle contraction, decreased pelvic floor muscle resistance, and increased residual urine volume, are some of the factors increasing the prevalence of urinary incontinence among people. For instance, elderly women have a greater risk for UTIs due to lower amounts of vaginal estrogen that change the vaginal climate, resulting in bacterial infections.

Moreover, the increasing company initiatives in developing technologically advanced equipment and products are also contributing to market growth. For instance, in March 2022, the Lok Nayak Hospital, Delhi, inaugurated a urodynamic video lab that provides real-time pictures of the urinary tract and bladder as well as immediate biofeedback. The lab has advanced equipment for studying urinary bladder dynamics, which helps in managing children with urological anomalies and diseases. Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the stringent regulatory policies for the validation of medical devices are likely to hinder the growth of the urodynamic equipment market over the forecast period.

Urodynamic Equipment Market Trends

The Uroflowmetry Equipment Segment is Expected to Hold Significant Market Share in the Market Over the Forecast Period

The uroflowmetry equipment segment is expected to witness significant growth in the urodynamic equipment market over the forecast period owing to factors such as the increasing burden of urological diseases such as urinary incontinence, rising chronically ill patients with the growing geriatric population, and technologically advanced products.

Uroflowmetry is a non-invasive diagnostic test used to diagnose patients with lower urinary tract symptoms. It measures the volume of urine released from the body, the speed with which it is released, and how long the release takes. It also aids in identifying the main cause and difficulties patient encounters while urinating. Thus, the accuracy in measuring the urine volume and assessing the exact reason and type of urological disease that causes urinary difficulties in the patients is high among these types of equipment as compared to other devices. This makes it more preferred, for most of the patients with suspected lower urinary tract dysfunction, over other devices.

Additionally, the rising incidences of benign prostate hyperplasia (BPH) condition in men also increases the need for uroflowmetry tests, which is expected to augment the segment's growth over the forecast period. For instance, from an article published by the National Center for Biotechnology Information in July 2021, it has been observed that the prevalence of BPH was 50% to 60% high in males in their 60s and 80% to 90% in those over 70 years of age. Furthermore, the increasing company activities in developing safe and effective diagnostic tests for measuring the urological condition among the population is also contributing to market growth. For instance, in November 2021, Oruba, a medical device company, launched the first self-operating uroflowmeter, Oruflow, that makes the screening procedure hygienic, safe, comfortable, and streamlined for both patients and physicians. Thus, owing to the aforementioned factors, the studied segment is expected to grow significantly during the forecast period.

North America is Anticipated to Hold a Major Share in the Market Over the Forecast Period

North America is expected to hold a significant share of the urodynamic equipment market over the forecast period. The factors attributed to the market growth are the increasing incidences of urological diseases and rising technological advancements in urodynamic equipment in the region. In addition, the rising geriatric population in the region is also expected to increase market growth. For instance, according to an article published by NCBI, in February 2021, it has been observed that urinary incontinence affects women disproportionately more than males and is significantly increased among women aged 60 years and older in the United States. Also, as per statistics published by the Fraser Institute, in July 2022, about 19% of the population living in Canada was aged 65 years and above, and this number is projected to reach 22.5% by 2030. Aging increases the risk of bladder problems such as bladder control issues and leakage or urinary incontinence. Thus, this is expected to increase the demand for urodynamic equipment for diagnosing and treating urological diseases over the forecast period.

Furthermore, the increasing product approvals and product launches in the region are also contributing to market growth. For instance, in July 2021, Gemini Medical Technologies launched a new line of urodynamics equipment by MEDKONSULT Medical Technology. Also, in February 2021, Health Canada approved Bactiguard's TempSensor catheter with a temperature sensor that reduces the risk of secondary infections such as catheter-associated urinary tract infection (CAUTI) in critically ill patients. Thus, owing to the aforementioned factors, the studied market is expected to grow significantly during the forecast period.

Urodynamic Equipment Market Competitor Analysis

The urodynamic equipment market is moderately competitive and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. And some prominent players are vigorously engaging in collaborations, acquisitions, and launching new products with other companies to consolidate their market positions across the globe. Some of the companies that are currently dominating the market are Medtronic Plc, Coloplast​, Albyn Medical S.L., Boston Scientific Corporation, Coopersurgical, Inc., Medical Measurement Systems B.V.​, Verathon, Inc. (Roper Technologies, Inc.), Karl Storz SE & Co. KG, and Olympus Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Urologic Diseases and Disorders
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Technological Advancements in Urodynamic Equipment
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies For Validation of Medical Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Urodynamic Equipment
      • 5.1.1.1 Cystometer
      • 5.1.1.2 Uroflowmetry Equipment
      • 5.1.1.3 Ambulatory Urodynamic Systems
      • 5.1.1.4 Electromyograph
      • 5.1.1.5 Video Urodynamic Systems
    • 5.1.2 Urodynamic Consumables
      • 5.1.2.1 Urodynamic Catheters
      • 5.1.2.2 Urodynamic Pumps and Transducer Sets
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Centers
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Coloplast​
    • 6.1.3 Albyn Medical S.L.
    • 6.1.4 Boston Scientific Corporation
    • 6.1.5 Coopersurgical, Inc.
    • 6.1.6 Laborie (Medical Measurement Systems B.V.)
    • 6.1.7 Verathon, Inc. (Roper Technologies, Inc.)
    • 6.1.8 Karl Storz SE & Co. KG
    • 6.1.9 Olympus Corporation
    • 6.1.10 Gemini Medical Technologies
    • 6.1.11 White Bridge Investments S.p.A (Delta Med S.p.A.)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS